Skip to main content

Factors Affecting Time to Surgery in Breast Cancer Patients.

Publication ,  Journal Article
Chagpar, AB; Howard-McNatt, M; Chiba, A; Levine, EA; Gass, JS; Gallagher, K; Lum, S; Martinez, R; Willis, AI; Fenton, A; Solomon, NL; Namm, JP ...
Published in: Am Surg
April 2022

BACKGROUND: We sought to determine factors affecting time to surgery (TTS) to identify potential modifiable factors to improve timeliness of care. METHODS: Patients with clinical stage 0-3 breast cancer undergoing partial mastectomy in 2 clinical trials, conducted in ten centers across the US, were analyzed. No preoperative workup was mandated by the study; those receiving neoadjuvant therapy were excluded. RESULTS: The median TTS among the 583 patients in this cohort was 34 days (range: 1-289). Patient age, race, tumor palpability, and genomic subtype did not influence timeliness of care defined as TTS ≤30 days. Hispanic patients less likely to have a TTS ≤30 days (P = .001). There was significant variation in TTS by surgeon (P < .001); those practicing in an academic center more likely to have TTS ≤30 days than those in a community setting (55.1% vs 19.3%, P < .001). Patients who had a preoperative ultrasound had a similar TTS to those who did not (TTS ≤30 days 41.9% vs 51.9%, respectively, P = .109), but those who had a preoperative MRI had a significantly increased TTS (TTS ≤30 days 25.0% vs 50.9%, P < .001). On multivariate analysis, patient ethnicity was no longer significantly associated with TTS ≤30 (P = .150). Rather, use of MRI (OR: .438; 95% CI: .287-.668, P < .001) and community practice type (OR: .324; 95% CI: .194-.541, P < .001) remained independent predictors of lower likelihood of TTS ≤30 days. CONCLUSIONS: Preoperative MRI significantly increases time to surgery; surgeons should consider this in deciding on its use.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Surg

DOI

EISSN

1555-9823

Publication Date

April 2022

Volume

88

Issue

4

Start / End Page

648 / 652

Location

United States

Related Subject Headings

  • Time-to-Treatment
  • Surgery
  • Retrospective Studies
  • Neoadjuvant Therapy
  • Mastectomy
  • Humans
  • Female
  • Breast Neoplasms
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chagpar, A. B., Howard-McNatt, M., Chiba, A., Levine, E. A., Gass, J. S., Gallagher, K., … Garcia-Cantu, C. (2022). Factors Affecting Time to Surgery in Breast Cancer Patients. Am Surg, 88(4), 648–652. https://doi.org/10.1177/00031348211054714
Chagpar, Anees B., Marissa Howard-McNatt, Akiko Chiba, Edward A. Levine, Jennifer S. Gass, Kristalyn Gallagher, Sharon Lum, et al. “Factors Affecting Time to Surgery in Breast Cancer Patients.Am Surg 88, no. 4 (April 2022): 648–52. https://doi.org/10.1177/00031348211054714.
Chagpar AB, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, et al. Factors Affecting Time to Surgery in Breast Cancer Patients. Am Surg. 2022 Apr;88(4):648–52.
Chagpar, Anees B., et al. “Factors Affecting Time to Surgery in Breast Cancer Patients.Am Surg, vol. 88, no. 4, Apr. 2022, pp. 648–52. Pubmed, doi:10.1177/00031348211054714.
Chagpar AB, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, Lum S, Martinez R, Willis AI, Fenton A, Solomon NL, Senthil M, Edmonson D, Namm JP, Walters L, Brown E, Murray M, Ollila D, Dupont E, Garcia-Cantu C. Factors Affecting Time to Surgery in Breast Cancer Patients. Am Surg. 2022 Apr;88(4):648–652.

Published In

Am Surg

DOI

EISSN

1555-9823

Publication Date

April 2022

Volume

88

Issue

4

Start / End Page

648 / 652

Location

United States

Related Subject Headings

  • Time-to-Treatment
  • Surgery
  • Retrospective Studies
  • Neoadjuvant Therapy
  • Mastectomy
  • Humans
  • Female
  • Breast Neoplasms
  • 3202 Clinical sciences
  • 1103 Clinical Sciences